Navellier & Associates Inc Fulgent Genetics, Inc. Transaction History

Navellier & Associates Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$49.85 - $96.11 $1.69 Million - $3.26 Million	-33,895 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$77.3 - $105.0 $294,822 - $400,470	3,814 Added 12.68%	33,895 $3.41 Million
Q3 2021 Oct 28, 2021	BUY	$74.87 - $110.87 $234,567 - $347,355	3,133 Added 11.63%	30,081 $2.71 Million
Q2 2021 Aug 09, 2021	BUY	$66.8 - $100.45 $292,584 - $439,971	4,380 Added 19.41%	26,948 $2.49 Million
Q1 2021 May 12, 2021	BUY	$59.3 - $183.85 $809,800 - $2.51 Million	13,656 Added 153.23%	22,568 $2.18 Million
Q4 2020 Feb 05, 2021	BUY	$31.01 - $52.1 $276,361 - $464,315	8,912 New	8,912 $464,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $513M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Navellier & Associates Inc with notifications on news.